Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replicationJ P Kleim, K. E. Schneweis, Arno Paessens et al.|Antimicrobial Agents and Chemotherapy|1995Cited by 85